It’s too soon to understand the effectiveness of a fourth vaccine dose, according to the EU’s top drug regulator. But some countries have already authorized the shot. Fourth doses of the COVID-19 vaccine don’t appear...
Millions of people around the world have received the BioNTech-Pfizer vaccine against COVID-19. Now the team behind BioNTech is receiving Germany’s biggest award for medicine. Three scientists from BioNTech, the German biotechnology company behind one...
The US and Canada now allow the BioNTech-Pfizer vaccine to be administered to teenagers. Germany could follow suit this summer. But how sensible are the coronavirus vaccines for those under 18? According to the US...
Russia’s COVID-19 vaccine, Sputnik V, has been approved for use in dozens of countries, and it’s also under review by the European Medicines Agency. But the vaccine remains controversial. President Vladimir Putin has touted Sputnik V...
The prospect of longer and warmer days in the Northern Hemisphere heralds the return of less favourable conditions for COVID-19 but instead we seem already to have entered a third wave of infections in Europe,...
A vaccine jointly developed by German company BioNTech and US firm Pfizer has proven to be 90% effective at preventing COVID-19 infections, according to phase 3 trials. German company BioNTech and its US partner Pfizer...
Whoever wins the race to come up with a successful coronavirus vaccine will also win massive profits. But while the industry vows to make a vaccine globally accessible, not all are on board with that...
The global trade with counterfeit drugs is booming – it’s an extremely lucrative business with potentially lethal side effects. Cross-border cooperation is trying to curb the deadly trade. The counterfeiters are unscrupulous: Painkillers are made...
Measles have has been stamped out in some countries – but not in Germany. A new wave of infection has rolled through Germany, prompting renewed discussion about compulsory vaccinations. A brownish-pink rash is the typical...
Indian scientists have developed a low-cost rotavirus vaccine that could prevent severe infant diarrhea. At $1 per dose, it could save thousands of children’s lives each year in Asia and Africa. At a fraction of...
